These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 4651208)

  • 21. Tremor and involuntary movements in monkeys: effect of L-dopa and of a dopamine receptor stimulating agent.
    Goldstein M; Battista AF; Ohmoto T; Anagnoste B; Fuxe K
    Science; 1973 Feb; 179(4075):816-7. PubMed ID: 4630708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopaminergic neurons: drug-induced antagonism of the increase in tyrosine hydroxylase activity produced by cessation of impulse flow.
    Walters JR; Roth RH
    J Pharmacol Exp Ther; 1974 Oct; 191(1):82-91. PubMed ID: 4153880
    [No Abstract]   [Full Text] [Related]  

  • 23. Some observations on the site of action of oxypertin.
    Fuxe K; Grobecker H; Hökfelt T; Jonsson J; Malmfors T
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 256(4):450-63. PubMed ID: 5622482
    [No Abstract]   [Full Text] [Related]  

  • 24. On the role of brain catecholamines in motor activity: experiments with inhibitors of synthesis and of monoamine oxidase.
    Svensson TH; Waldeck B
    Psychopharmacologia; 1970; 18(4):357-65. PubMed ID: 5491473
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparison of effects of apomorphine and ET495 on locomotor activity and circling behaviour in mice.
    Thornburg JE; Moore KE
    Neuropharmacology; 1974 Mar; 13(3):189-97. PubMed ID: 4858216
    [No Abstract]   [Full Text] [Related]  

  • 26. On spinal noradrenaline receptor supersensitivity: correlation between nerve terminal densities and flexor reflexes various times after intracisternal 6-hydroxydopamine.
    Nygren LG; Olson L
    Brain Res; 1976 Nov; 116(3):455-70. PubMed ID: 974787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereoisomers of viminol: catalepsy and brain monoamine turnover rate.
    Costa E; Cheney D; Revuelta A
    Adv Biochem Psychopharmacol; 1973; 8(0):483-94. PubMed ID: 4800183
    [No Abstract]   [Full Text] [Related]  

  • 28. Reduction of morphine's effect on striatal dopamine metabolism in rats treated with a low dose of apomorphine or agents increasing serotonin transmission.
    Spampinato U; Invernizzi R; Nowakowska E; Samanin R
    Biochem Pharmacol; 1984 Jan; 33(1):163-5. PubMed ID: 6704139
    [No Abstract]   [Full Text] [Related]  

  • 29. Evidence for a new type of dopamine receptor stimulating agent.
    Corrodi H; Fuxe K; Ungerstedt U
    J Pharm Pharmacol; 1971 Dec; 23(12):989-91. PubMed ID: 4402038
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons.
    Corrodi H; Fuxe K; Hökfelt T; Lidbrink P; Ungerstedt U
    J Pharm Pharmacol; 1973 May; 25(5):409-12. PubMed ID: 4146398
    [No Abstract]   [Full Text] [Related]  

  • 31. Development of tolerance in rats to the hypothermic effects of D-amphetamine and apomorphine.
    Chiel H; Yehuda S; Wurtman RJ
    Life Sci; 1974 Feb; 14(3):483-8. PubMed ID: 4150950
    [No Abstract]   [Full Text] [Related]  

  • 32. In vivo enhancement of tyrosine hydroxylation in rat striatum by tetrahydrobiopterin.
    Kettler R; Bartholini G; Pletscher A
    Nature; 1974 May; 249(456):476-8. PubMed ID: 4834235
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects on striatal and mesolimbic dopamine systems of a new potential antipsychotic drug -mezilamine- with weak cataleptogenic properties.
    Uzan A; Le Fur G; Mitrani N; Kabouche M; Donadieu AM
    Life Sci; 1978 Jul; 23(3):261-73. PubMed ID: 29181
    [No Abstract]   [Full Text] [Related]  

  • 34. Ethanol and caffeine: a complex interaction with respect to locomotor activity and central catecholamines.
    Waldeck B
    Psychopharmacologia; 1974 Apr; 36(3):209-20. PubMed ID: 4846326
    [No Abstract]   [Full Text] [Related]  

  • 35. Failure of catecholamine development following unilateral diencephalic lesions in the neonatal rat.
    Erinoff L; Heller A
    Brain Res; 1973 Aug; 58(2):489-93. PubMed ID: 4756139
    [No Abstract]   [Full Text] [Related]  

  • 36. Pentylenetetrazol convulsions and brain catecholamine turnover rate in rats and mice receiving diphenylhydantoin or benzodiazepines.
    Doteuchi M; Costa E
    Neuropharmacology; 1973 Nov; 12(11):1059-72. PubMed ID: 4768639
    [No Abstract]   [Full Text] [Related]  

  • 37. Decrease of dopamine and 5-hydroxytryptamine after intracerebral application of 5,6-dihydroxytryptamine.
    Saner A; Pieri L; Moran J; Da Prada M; Pletscher A
    Brain Res; 1974 Aug; 76(1):109-17. PubMed ID: 4844098
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of trivastal, haloperidol and dibutyryl cyclic AMP on (14C)dopamine synthesis in rat striatum.
    Goldstein M; Anagnoste B; Shirron C
    J Pharm Pharmacol; 1973 Apr; 25(4):348-51. PubMed ID: 4146696
    [No Abstract]   [Full Text] [Related]  

  • 39. Biochemical aspects of dopamine agonists.
    Kehr W; Carlsson A; Lindqvist M
    Adv Neurol; 1975; 9():185-95. PubMed ID: 1146653
    [No Abstract]   [Full Text] [Related]  

  • 40. Interaction of bradykinin with dopaminergic receptors in the CNS.
    Moniuszko-Jakoniuk J; Wiśniewski K
    Pol J Pharmacol Pharm; 1977; 29(3):301-11. PubMed ID: 887505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.